Harbor Biomedicines

Boston, MA Cell & gene therapy, Platform

Therapies

Gene insertion technology

Overview

Harbor Biomedicines, a Harvard/Wyss Institute spinoff, is pioneering a safe and efficient gene insertion technology to provide curative treatments for rare genetic and common disorders. By engineering compact, simple yet potent enzymes — recombinases — Harbor Biomedicines can efficiently and precisely integrate large DNA cargos into genomic safe harbors for robust and durable therapeutic gene expression, with an initial focus on liver and blood cell editing.

Leadership

See all alumni